Founded by Dr. Mark Mofid, a plastic surgeon who saw firsthand how existing wound closures fail. Traditional cyanoacrylates (like Dermabond) create a barrier that traps moisture and inhibits natural healing. SYLKE's silk fibroin does the opposite—it's biocompatible, biodegradable, and works with the body's healing mechanisms. With only 21 employees generating $5.6M in revenue, they're achieving $267K per employee—exceptional efficiency for a medical device company still scaling.

Here's the uncomfortable truth: 68.9% of their traffic is 'undefined'—a stark indicator they're still building brand recognition. They rank for just 2,000 monthly searches for 'sylk' and only 480 for 'derma bond,' the category leader. But this isn't failure; it's early-stage opportunity. Their 48% direct traffic shows the ones who find them, remember them. The 22% organic traffic proves their story resonates enough to convert searchers.